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Aﬂatoxins (AF) are a group of mycotoxins. AF exposure causes acute and chronic adverse health effects such as
aﬂatoxicosis and hepatocellular carcinoma in human populations, especially in the developing world. In this study, AF
exposure was evaluated using archived serum samples from human immunodeﬁciency virus (HIV)-seronegative partici-
pants from two cohort studies in south-western Uganda. AFB1–lysine (AFB-Lys) adduct levels were determined via HPLC
ﬂuorescence in a total of 713 serum samples from the General Population Cohort (GPC), covering eight time periods
between 1989 and 2010. Overall, 90% (642/713) of the samples were positive for AFB-Lys and the median level was
1.58 pg mg−1 albumin (range = 0.40–168 pg mg−1 albumin). AFB-Lys adduct levels were also measured in a total of 374
serum samples from the Rakai Community Cohort Study (RCCS), across four time periods between 1999 and 2003. The
averaged detection rate was 92.5% (346/374) and the median level was 1.18 pg mg−1 albumin (range = 0.40–122.5 pg mg−1
albumin). In the GPC study there were no statistically signiﬁcant differences between demographic parameters, such as age,
sex and level of education, and levels of serum AFB-Lys adduct. In the RCCS study, longitudinal analysis using generalised
estimating equations revealed signiﬁcant differences between the adduct levels and residential areas (p = 0.05) and
occupations (p = 0.02). This study indicates that AF exposure in people in two populations in south-western Uganda is
persistent and has not signiﬁcantly changed over time. Data from one study, but not the other, indicated that agriculture
workers and rural area residents had more AF exposure than those non-agricultural workers and non-rural area residents.
These results suggest the need for further study of AF-induced human adverse health effects, especially the predominant
diseases in the region.
Keywords: aﬂatoxins; aﬂatoxin B1–lysine adduct; human exposure; Uganda; cohort studies
Introduction
Aﬂatoxins (AF), mainly produced by Aspergillus ﬂavus
and A. parasiticus, represent a group of naturally occur-
ring fungal metabolites (mycotoxins) that have long been
recognised as hazardous contaminants of food, especially
in peanuts, corn/maize and dried cassava (Busby &
Wogan 1984; Wang et al. 1998; Williams et al. 2004).
Aﬂatoxin B1 (AFB1) is a potent hepatotoxic and genotoxic
agent (Essigmann et al. 1977; Wang & Groopman 1999),
and has been evaluated as a Group I human carcinogen
(sufﬁcient evidence of carcinogenicity to humans) by the
IARC, WHO (IARC 1993, 2002). Exposure to high levels
of AFB1 via the diet causes acute hepatotoxicity (aﬂatox-
icosis) and death in humans, as demonstrated by recent
outbreaks in Kenya, which were responsible for the deaths
of more than 150 people (Azziz-Baumgartner et al. 2005;
Lewis et al. 2005). Chronic exposure to low levels of
AFB1 is a risk factor in the aetiology of human hepato-
cellular carcinoma (HCC) in several regions of Africa and
Southeast Asia, particularly in conjunction with hepatitis
B virus infection (IARC 1993, 2002; Wild & Hall 2000;
Wogan et al. 2012). Importantly, AFB1 has also been
shown to be an anti-nutritional agent that reduces concen-
trations of vitamins and proteins in animals and humans
(Gong et al. 2002; Williams et al. 2004; Wild 2007; Tang
et al. 2009). Further, it is a potent immunotoxic agent in
animals and also changes T-cell phenotypes in humans,
which may aggravate the burden of infectious diseases in
the developing world (Williams et al. 2004; Jiang et al.
2005; Wild 2007).
AF contamination is an important problem in relation
to food quality/food safety in Africa as a result of poor
production and storage practices for major staples of the
African diet (Hell et al. 2000; Williams et al. 2004, 2010;
Lewis et al. 2005). Studies in Uganda indicate that AF
exposure is broadly similar to that reported from other
African countries (Kaaya & Warren 2005). The environ-
mental conditions in parts of Uganda are ideal for
Aspergillus growth during crop cultivation and storage in
the subsequent post-harvest period due to improper drying
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and inadequate storage conditions. AF contamination has
been reported in maize, cassava, groundnuts and locally
manufactured baby foods including baby soya and rice
porridge (Williams et al. 2004, 2010; Kaaya & Eboku
2010; Kitya et al. 2010).
Human exposure to AF and its linkage to adverse
health effects in various human populations have been
well studied in some West African countries (Williams
et al. 2004, 2010), as well as in Kenya (Azziz-
Baumgartner et al. 2005; Lewis et al. 2005; Yard et al.
2013), a neighbouring country to Uganda. However, no
human exposure studies have ever been assessed in
Uganda with the exception of an earlier pilot investigation
in small numbers of children and a recent pilot study
(Wild et al. 1990; Asiki et al. 2014), although a link
between AF and hepatoma was suggested decades ago in
Uganda (Alpert et al. 1968, 1971; Serck-Hanssen 1970).
In order to explore further the relationships between AF
exposure, archived serum samples previously collected
from two existing cohort studies in the central and
south-west regions of Uganda were analysed for AFB1–
lysine adduct (AFB-Lys) levels to evaluate AF exposure in
these human populations.
Materials and methods
Study populations and study samples
The geographic locations of both cohort study sites are
indicated on the map of Uganda (Figure 1). The General
Population Cohort (GPC) was established by the UK
Medical Research Council/Uganda Virus Research
Institute (MRC/UVRI) in 1989, and sampling was initially
conducted in 15 rural villages (expanded to 25 villages in
2000) in a sub-county of Masaka district located in south
western Uganda (Asiki et al. 2013). This is an open-cohort
study, with new births, deaths, inward and outward migra-
tion reported at each round of follow-up. The total popula-
tion covered is about 22 000 people, and there is no age
limit. Every year since its inception, data were collected
on annual household censuses of the resident population
covering age, sex, education and relationship to household
head. A medical sero-survey was conducted in participants
aged 13 years and above (although some rounds also
include all children), including collection of blood speci-
mens for human immunodeﬁciency virus (HIV) testing
and a brief behavioural questionnaire.
The Rakai Community Cohort Study (RCCS), initiated
in 1987 in Rakai District, south-western Uganda, is a
collaborative study conducted by the Ministry of Health
through the UVRI, Makerere University and Johns
Hopkins University. The current cohort, which consists
of some of the adult residents in 50 villages, was estab-
lished in 1994–95 (Wawer et al. 1991; Sewankambo et al.
1994; Gray et al. 1998). All participants are followed
annually in their homes, at which time they provide per-
sonal information (demographics, education, current and
past sexual behaviours, and sexually transmitted infection
history) through surveys, and blood samples were col-
lected for detection of HIV, sexually transmitted diseases
(STDs) and other infections. This is an open cohort of
adults aged 15–49 years, which enrols new immigrants
and age-eligible residents at each survey visit annually.
The numbers of participants under surveillance are main-
tained between the ranges of 12 000–16 000 annually. The
main objectives of these two cohort studies are similar: to
study the dynamics of HIV infection; to identify major risk
factors; and to measure the impacts of HIV infection on
mortality and fertility. However, there are two important
differences between the GPC and the RCCS. Firstly, the
GPC is concentrated in one sub-county of Masaka
District, working in contiguous villages, while the RCCS
study communities were selected to represent different
parts of the district, so are scattered across the area.
Secondly, the GPC includes all age groups, from infants
to the very old, and the RCCS focuses on collecting data
in age groups between 15 and 49 years.
Archived serum samples were randomly selected from
GPC samples collected in 1989, 1992, 1995, 1998, 2001,
2004, 2007 and 2010, and from the RCCS samples col-
lected in 2000, 2001, 2002 and 2003, respectively. A total
of 713 and 374 archived sample were thawed and aliquots
were separated, stored on dry ice, and shipped via air for
the analysis of AFB-Lys adducts at the College of Public
Health, University of Georgia (UGA), Athens, Georgia,
USA, with the import permit issued by the US Centers for
Disease Control and Prevention (CDC). All samples
selected for this analysis were HIV negative.
Figure 1. Uganda and the geographic distribution of GPC and
RCCS study sites.
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Materials for laboratory analysis
AFB1 (> 98% purity), albumin determination reagent,
bromocreosol purple and normal human serum were pur-
chased from Sigma Aldrich Chemical Co. (St Louis, MO,
USA). Protein assay dye reagent concentrate and protein
standards were purchased from Bio-Rad Laboratories Inc.
(Hercules, CA, USA). Pronase (25 kU, Nuclease-free) was
purchased from Calbiochem (La Jolla, CA, USA). Mixed-
mode SPE cartridges were purchased from Waters Corp.
(Milford, MA, USA). Authentic AFB-Lys was synthesised
as previously described (Sabbioni et al. 1987). The
authentic AFB-Lys standard was puriﬁed and charac-
terised by UV absorption and mass spectrometry
(Sabbioni et al. 1987; Wang, Abubaker, et al. 2001). All
other chemicals and solvents used were of the highest
grade commercially available.
Measurement of serum AFB-Lys adducts
Serum samples were coded separately and analysed with a
newly developed HPLC-ﬂuorescence method (Qian et al.
2013). Brieﬂy, thawed human serum samples were heated
to 56°C for 30 min to inactivate infectious microbial
agents. Total protein and albumin concentrations were
determined using a modiﬁcation of a previously described
method (Wang et al. 1996). A portion of each serum
sample (150 μl) was digested by pronase (pronase:total
protein, 1:4, w/w) at 37°C for 3 h to release the AFB-Lys
adduct. The serum sample digests were subjected to SPE
clean-up using Waters MAX SPE cartridges, which had
been conditioned with methanol and equilibrated with
water prior to loading with the AFB-Lys containing
digests. The loaded cartridges were sequentially washed
by water, 70% methanol and 1% ammonium hydroxide in
methanol at a ﬂow rate of 1 ml min–1. Puriﬁed AFB-Lys
was eluted with 2% formic acid in methanol. The eluent
was vacuum dried with a Labconco Centrivap concentra-
tor (Kansas City, MO, USA) and reconstituted for HPLC-
ﬂuorescence detection. The analysis of AFB-Lys adduct
was conducted in an Agilent 1200 HPLC-ﬂuorescence
system (Santa Clara, CA, USA). The mobile phases con-
sist of buffer A (20 mM NH4H2PO4, pH 7.2) and buffer B
(100% methanol). The Zorbax Eclipse XDB-C18 reverse
phase column (5 μm, 4.6 × 250 mm) equipped with a
guard column was used. Column temperature was main-
tained at 25°C during analysis, and a volume of 100 μl
was injected into the HPLC. The ﬂow rate was kept at
1 ml min–1. A gradient was generated to separate the
AFB-Lys adduct within 25 min of injection. The AFB-
Lys adduct was detected by ﬂuorescence at maximum
excitation and emission wavelengths of 405 and 470 nm,
respectively. Calibration curves of authentic standard were
generated weekly, and the standard AFB-Lys was eluted at
approximately 13.1 min. Quality assurance and quality
control procedures were conducted during analyses,
which include the analysis of one authentic standard and
a quality control sample daily in the same sequence. The
LOD was 0.4 pg mg−1 albumin. The average recovery rate
with various spiked concentrations of AFB-Lys adduct
standard was 90%. The serum AFB-Lys concentration
was normalised to albumin content for statistical analysis
and report. The technicians who perform the analyses had
no information about sample sources, which guaranteed
conﬁdentiality.
Statistical analysis
An Excel database was established to include the AFB-
Lys adduct level and other demographic information. Data
analysis was performed using SAS software version 9.1
(SAS Institute, Cary, NC, USA). Levels of AFB-Lys
adducts in the groups with different demographic para-
meters such as age, gender, area, occupation and education
were compared. Since participants in both cohorts pro-
vided serum samples multiple times, longitudinal analysis
for repeated measure was used. Generalised estimating
equations were used to handle the inconsistent participa-
tion of some participants and non-normal distribution of
the AFB-Lys adduct in serum. We separately analysed the
datasets from the GPC and RCCS due to the discrepancy
of baseline demographic factors in both cohorts, which
was tested by χ2- and t-tests. The monotonic trend of
AFB-Lys across rounds (time) in participants was esti-
mated by a Wilcoxon-type test for trend and generalised
estimating equations (Cuzick 1985). Temporal variation of
AFB-Lys was analysed using a Kruskal–Wallis test. Box
plot analysis was done through SigmaPlot 10.0 (San Jose,
CA, USA). A p-value of less than 0.05 was considered to
be statistically signiﬁcant.
Ethics
Ethical approval for this study was granted by the UVRI
Science Ethics Committee and the Uganda National
Council of Science and Technology. The laboratory
study protocol of serum sample analysis for the AFB-
Lys adduct was approved by the Institutional Review
Board for Human Subject Protection at the University of
Georgia.
Results
Demographic information for study participants at both
cohort sites is described in Table 1. As shown, there
were signiﬁcant differences between the two cohort
study sites on basic demographic parameters in terms of
age, sex, area of residency, occupation and education
level. Thus, the statistical analysis was done separately.
Food Additives & Contaminants: Part A 3
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AFB-Lys adduct levels in a total of 713 archived GPC
serum samples were determined at eight separate time
points between 1989 and 2010. Longitudinal temporal
variations of AFB-Lys adduct levels in these serum sam-
ples are shown in Table 2 and Figure 2. The averaged
detection rate was 90% (642/713) and the median level
was 1.58 pg mg−1 albumin (range = 0.40–168 pg mg−1
albumin) over all analysed cohort samples. There was
statistically signiﬁcant variation across the various rounds
(p < 0.0001), showing the great increase of AFB-Lys
adduct for rounds 9–21, representing 1998–2010,
However, there was no monotonic increase in detection
rates and the median level of serum AFB-Lys adduct
among eight rounds (Ptrend = 0.073), Further longitudinal
analysis using generalised estimating equations for the
AFB-Lys adduct did not show signiﬁcant differences
between demographic parameters, such as age, gender,
residence, occupation and level of education (Table 4).
AFB-Lys adduct levels in a total of 374 archived
Rakai RCCS serum samples were determined according
to four consecutive rounds of sample collections, repre-
senting 2000–03. Longitudinal temporal variations of
AFB-Lys adduct levels in these serum samples are
shown in Table 3 and Figure 3. The averaged detection
rate was 92.5% (346/374) and the median level was
1.18 pg mg−1 albumin (range = 0.40–122.5 pg mg−1
albumin) over all analysed cohort samples. There was a
signiﬁcant variation across four round (p = 0.0006), show-
ing increasing AFB-Lys adducts in 2001–03, but there was
no statistical signiﬁcance in the increasing trend of the AF
exposure in RCCS (Figure 3, Ptrend = 0.061). Although
there were no signiﬁcant differences between demographic
parameters such as age, gender and level of education with
sorted AFB-Lys adduct levels (Table 4), analysis using
generalised estimating equations revealed signiﬁcant dif-
ferences between levels of AFB-Lys adducts and
Table 2. AFB-Lys adduct levels (pg mg−1 albumin) in the GPC study participants over time.
Round (year)
R1 (1989) R3 (1992) R6 (1995) R9 (1998) R12 (2001) R15 (2004) R18 (2007) R21 (2010) Total
Number 87 11 86 49 80 128 141 131 713
Mean 3.09 2.71 5.62 1.06 1.51 1.89 3.00 3.12 2.85
SD 3.70 1.43 22.46 1.05 1.70 1.62 4.07 3.69 8.37
Median 1.82 2.44 1.50 0.77 0.92 1.46 2.03 1.93 1.58
Minimum 0.40 1.02 0.4 0.4 0.4 0.4 0.4 0.4 0.4
Maximum 22.5 5.16 168 5.18 11.6 7.7 32.3 24.08 168.0
Prevalence of 95.4 100 95.3 83.7 81.3 85.2 91.5 93.9 90.0
detectable
AFB-Lys (%)
(83/87) (11/11) (82/86) (41/49) (65/80) (109/128) (129/141) (123/131) (642/713)
Table 1. Demographic information for participants in two study
sites.
GPC site RCCS site p-value
Sex
Male 183 151 0.0034
Female 174 223
Age (mean ± SD) 44.3 ± 18.6 30.2 ± 9.76 < 0.001
Area of residency
Rural 357 314 < 0.0001
Semi-urban – 60
Occupation
Agriculture 323 233 < 0.0001
Others 34 141
Level of education
Never 54 23 < 0.0001
Primary 261 227
Secondary and above 42 124
HIV status
Negative 357 374
Positive – –
Note: p-values were obtained by a χ2 test (sex, area, occupation, educa-
tion) and a t-test (age).
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Figure 2. Temporal variations of AFB-Lys adduct level in GPC
study participants. The box plots show the distribution of serum
AFB-Lys adducts levels in each round. Box values ranged from
the 25th to the 75th percentile of total samples, the line within it
indicating the median value. Bars on both sides of a box repre-
sent values ranging from the 5th to 25th percentile and from the
75th to the 95th percentile, respectively.
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residential areas (p = 0.045) and occupations (p = 0.016)
in this cohort samples, as demonstrated in Table 4.
Discussion
This study showed that AF exposure is almost ubiqui-
tous in study participants from both cohorts, as evi-
denced by the detection rate above 90% and the
constant detection of AFB-Lys adduct in these cohort
serum samples throughout different times. These results
also suggested the universal contamination of AF in the
food supply in south-western regions of Uganda. AF
contamination in food has been a long-term problem
in Uganda (Alpert et al. 1971; Kaaya & Warren 2005;
Kitya et al. 2010).
While contamination by the AF-producing Aspergillus
fungi may be universal within a given geographical area, the
levels or ﬁnal concentration of AF in the grain product can
vary from < 1 µg kg–1 (1 ppb) to > 12 000 µg kg–1 (12 ppm)
(Gan et al. 1988). For this reason, the measurement of human
consumption of AF by sampling foodstuffs is imprecise.
Further, obvious contamination of a commodity with the
fungi does not necessarily demonstrate the presence of AF,
and the appearance of a sound, uninfected sample of com-
modity does not preclude the existence of signiﬁcant quan-
tities of AFs (IARC 2002; Kaaya & Kyamuhangire 2006).
Therefore, accurate assessment of human AF exposure using
the biomarker approach has been highly recommended in the
past 20 years. AFB-Lys adduct in serum albumin has been
proven to be the most reliable exposure biomarker (Sabbioni
et al. 1987; Qian et al. 2010, 2013). As a result of its longer
in vivo half-life as compared with other urinary AFB1 meta-
bolites, such as AFM1 and AFB-N
7-guanine, the AFB-Lys
adduct can reﬂect integrated exposures over 2–3 months.
The long-term stability (up to 20 years) in frozen serum or
plasma made this adduct a ﬁrst choice of biomarkers to study
human AF exposure and its link to diseases (Wang et al.
1996; Wang, Abubaker, et al. 2001; Scholl & Groopman
2008). Highly signiﬁcant associations between AFB-Lys
adduct level and dietary AFB1 exposure have been found
in human populations from several regions of the world. In
addition, AFB-Lys adduct has been used as a biological
response indicator of acute and chronic human diseases,
such as aﬂatoxicosis in Africa, risks of HCC in Taiwan,
China and Africa, and infectious disease-linked immune
suppression (Wang et al. 1996, 1998; Wang, Huang, et al.
2001; Turner et al. 2003; Azziz-Baumgartner et al. 2005;
Lewis et al. 2005). Moreover, the AFB-Lys adduct has been
used as the primary biomarker to assess the efﬁcacy of
several human chemoprevention and intervention trials
(Tang et al. 2008; Wild & Hall 2000; Wang, Abubaker,
et al. 2001; Wang et al. 2008). Therefore, application of the
AFB-Lys adduct is a signiﬁcant tool as an optimal biomarker
for studying global public health concern on AF-associated
human adverse health effects and evaluating efﬁcacies of
various intervention or prevention strategies, especially in
the developing world.
The present data are consistent with the previous
reported cross-sectional pilot study in GPC samples col-
lected in 2011 (Asiki et al. 2014). The geometric means of
Table 3. AFB-Lys adduct levels (pg mg−1 albumin) in RCCS study participants over time.
Round (year)
R6 (2000) R7 (2001) R8 (2002) R9 (2003) Total
Number 84 146 128 14 374
Mean 5.71 2.35 2.95 6.55 3.46
SD 11.8 4.22 11.2 8.82 9.25
Median 1.86 1.11 1.12 2.31 1.18
Minimum 0.40 0.40 0.40 0.40 0.4
Maximum 94.8 26.0 122.5 30.9 122.5
Prevalence of detectable AFB-Lys (%) 95.2 94.5 89.8 78.6 92.5
(80/84) (138/146) (115/128) (11/14) (346/374)
Round
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Figure 3. Temporal variations of AFB-Lys adduct levels in
RCCS study participants. Box plots show the distribution of
serum AFB-Lys adducts levels in each round. Box values ranged
from the 25th to the 75th percentile of the total samples, the line
within it indicating the median value. Bars on both sides of a box
represent values ranging from the 5th to the 25th percentile and
from the 75th to the 95th percentile, respectively.
Food Additives & Contaminants: Part A 5
D
ow
nl
oa
de
d 
by
 [1
96
.0.
26
.16
3]
 at
 22
:40
 24
 Ju
ly 
20
15
 
Table 4. AFB-Lys adduct levels in all participants according to selected demographic characteristics.
Number Detection rate (%) Geometric mean Median (95 % CI) 25th percentile 75th percentile 90th percentile p-valuea
GPCsite
Sex
Male 183 87.4 1.63 1.56 (0.4–7.25) 0.81 3.09 7.25 0.367
Female 174 90.8 1.75 1.84 (0.40–8.20) 0.93 2.79 4.54
Residential area
Rural 357 89.1 1.69 1.71 (0.4–7.63) 0.87 3.07 5.5 –
Occupation
Agriculture 323 88.9 1.63 1.66 (0.4–7.16) 0.86 2.85 5.26 0.464
Others 34 91.2 2.19 2.41 (0.4–11.33) 1.06 4.54 7.7
Education
None 54 90.7 1.9 1.97 (0.4–11.33) 0.95 3.52 7.47 0.386
Primary 261 88.5 1.66 1.62 (0.4–7.02) 0.87 2.87 5.26
Secondary or higher 42 90.5 1.69 1.78 (0.4–6.05) 0.79 2.99 5.16
Age (years)
< 20 24 79.2 1.2 1.05 (0.4–4.1) 0.66 2.34 3.96 0.348
20–39 56 92.9 1.96 1.75 (0.4–15.34) 1.03 3.13 6.79
40–59 194 89.7 1.68 1.7 (0.4–7.47) 0.89 2.71 5.89
> 60 83 88.0 1.64 1.8 (0.4–7) 0.69 3.39 5.29
RCCS site
Sex
Male 151 92.1 1.49 1.11 (0.4–14.2) 0.74 2.48 6.32 0.975
Female 223 92.8 1.53 1.25 (0.4–13) 0.68 2.63 7.39
Residential area
Rural 314 93.3 1.58 1.25 (0.4–18.2) 0.72 2.63 6.84 0.045
Semi-urban 60 88.3 1.21 0.95 (0.4–8.34) 0.67 1.87 4.85
Occupation
Agriculture 233 91.4 1.59 1.19 (0.4–20.92) 0.68 2.66 9.93 0.016
Others 141 94.3 1.39 1.17 (0.4–6.32) 0.75 2.43 5.08
Education
None 23 91.3 2.06 1.05 (0.4–5.93) 0.71 1.82 3.14 0.493
Primary 227 93.4 1.46 1.3 (0.4–15.6) 0.73 2.85 8.14
Secondary or higher 124 91.9 1.52 1.07 (0.4–8.14) 0.69 2.26 5.13
Age (years)
< 20 42 90.5 1.33 0.99 (0.4–5.83) 0.58 1.98 4.57 0.404
20–39 257 91.4 1.59 1.30 (0.4–15.59) 0.72 2.95 7.39
40–59 75 97.3 1.37 1.04 (0.44–20.01) 0.74 2.01 5.39
Note: aLongitudinal analysis using generalised estimating equations.
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AFB-Lys in our GPC study was 1.62 pg mg−1 albumin
and 1.66 pg mg−1 albumin in RCCS, which is different
from the geometric mean of 11.5 pg mg−1 albumin in that
report (Asiki et al. 2014). The difference possibly origi-
nated from different analytical methods for AFB-Lys mea-
surement: the HPLC-ﬂuorescence detection was used in
our study, and the ELISA method was used in that study.
Another explanation would be the difference of dietary
pattern changes, study designs and source of samples. In
contrast to the pilot study using cross-sectional design for
samples only collected in 2011, which may reﬂect recent
dietary pattern changes in GPC study participants, our
longitudinal study design reﬂects temporal pattern of the
AFB-Lys adduct levels from 1989 to 2010. Additionally,
our study used archived serum samples in both cohorts.
Even though the AFB-Lys adduct has been shown to have
a long-term stability over 20 years under proper storage
conditions (Wang et al. 1996; Wang, Abubaker, et al.
2001; Scholl & Groopman 2008), the repeated thaw and
freeze cycle of these samples may degrade the adduct
level in the original samples. Nevertheless, by using long-
itudinal study design and a more accurate detection
method for AFB-Lys measurement, our study shows the
constant AF exposure over 21 years and provides better
estimates of AF exposure in central and south-western
Ugandan populations.
Compared with other African countries, the averaged
AFB-Lys level found in this study was among those lower
levels reported. Yard et al. (2013) suggested that the esti-
mated AFB-Lys adduct values from the ELISA method is
typically 4.6 times higher than that from the HPLC-ﬂuor-
escence measurement. If taking their proposed 4.6 conver-
sion, the AFB-Lys adduct level in our study using GPC
study samples is similar to that of Asiki et al. (2014). The
averaged adduct level is actually higher than the levels
found in children from Kikelelwa, Tanzania (0.78 pg
mg−1 albumin after conversion by division of 4.6)
(Shirima et al. 2013; Yard et al. 2013). However, the adduct
level is still lower than averaged levels found from neigh-
bouring countries, such as Kenya and Tanzania, and West
African countries, such as Ghana, Gambia, Benin and Togo
(Gong et al. 2002, 2012; Ofori-Adjei 2012; Shirima et al.
2013). This may be again due to different diet patterns in
study participants or different AF exposure levels, or the
degradation of AFB-Lys adducts in our serum samples
analysed. Also, direct comparisons between countries may
not be valid because of different study designs, various
analytical methods used and seasonal variations of sample
collections. However, considering the consistency in our
data and the data from Asiki et al. (2014), there is no doubt
that human populations residing in south-western Uganda
have been constantly exposed to AF via their diets.
Exposure to AF has been documented in Uganda since
1967 when AF contamination was found in peanuts sold
for human consumption (Lopez & Crawford 1967).
Approximately 30% of the sampled human food items
(n = 480) were positive for AF contamination and 7.7%
(37/480) had concentrations of total AF between 100 and
1,000 ppb (Alpert et al. 1971; Kaaya & Warren 2005).
About 60–88% of the corn samples collected from three
agro-ecological zones contained detectable levels of AF
contamination with AFB1 as the dominant type found in
86–100% of corn samples cross zones (Kaaya &
Kyamuhangire 2006). A more recent study found AF
contamination in common processed food samples col-
lected from south-western Uganda, covering ground nuts,
cassava, millet, sorghum ﬂour and Eshabwe sauce, which
is a traditional food in this region made from milk and
cheese (Kitya et al. 2010). The mean of AF levels in these
food items (n = 90) was 15.7 ppb (range = 0–55) with
82.2% (74/90) exceeding the regulatory levels of the
European Union (4 ppb for processed food).
In this study we also found that the serum samples from
participants of rural areas had a signiﬁcantly higher AFB-
Lys adduct levels than samples from semi-urban residents
in the RCCS cohort, whereas no such a difference can be
examined in GPC samples because all study participants
were recruited from rural areas. Food resources of rural
residents are usually limited, dependent on local produc-
tions and highly reliant on natural environmental conditions
(Huang & Bouls 1996; Romanik 2008; Mukwaya et al.
2012). Their food production in rural Uganda is vulnerable
to toxigenic Aspergillus growth during crop cultivation, and
higher AF contamination may occur due to inadequate
post-harvest drying and improper storage practices. Thus,
rural populations are likely to be exposed to higher levels of
AF. On the other hand, residents in semi-urban areas
usually have better economic status and have a better
chance to access diverse food items such as meat, ﬁsh and
fruit rather than just cereal or other staples such as bananas
(Huang & Bouls 1996; Mukwaya et al. 2012). According to
a survey conducted in Malawi, 90% of food consumed by
households in urban area is purchased, whereas only 30%
of food consumed in rural areas is purchased in markets
(Romanik 2008). The diverse food items other than AF-
contaminated grains will protect residents in semi-urban
areas from high AF exposure. Also, rural populations suffer
poverty more frequently than urban populations in Uganda
(Mukwaya et al. 2012). The association of AF exposure
with poverty has been well proven (Shuaib et al. 2012;
Adejumo et al. 2013).
In summary, our study showed that AF exposure has been
a constant problem over decades in central and south-western
Ugandan. It has been well documented that AF exposure is
correlated to an increased risk of HCC, immune modulations
and anti-nutrition in human populations (Williams et al.
2004; Wild 2007). How AF exposure impacts human health
in these regions needs to be further explored, especially for its
linkage to the aggravation of infectious diseases, such as HIV,
and the disturbance of growth and development in children.
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